Floatz logo

Etanidazole

Adult Pilocytic Astrocytoma

National Cancer Institute (NCI)Small moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Adult Pilocytic Astrocytoma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Novartis Pharmaceuticals
Phase 2BB
Carboplatin
Novartis Pharmaceuticals
Phase 2BB
gsk1120212
Novartis Pharmaceuticals
Phase 4BB
Dabrafenib
Novartis Pharmaceuticals
Phase 4BB
ETOPOSIDE
Washington University School of Medicine
Phase 2CCC

View all 17 →

Same molecule, other indications

Etanidazole is also rated in:

adult anaplastic ependymomaDormant
D
Indicative ·
30 / 100
View asset →
anaplastic oligodendrogliomaDormant
D
Indicative ·
30 / 100
View asset →
anaplastic astrocytomaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →